1994 - Fellow of the American Psychological Association (APA)
Cognitive Function at 3 Years of Age after Fetal Exposure to Antiepileptic Drugs
Kimford J. Meador;Gus A. Baker;Nancy Browning;Jill Clayton-Smith.
The New England Journal of Medicine (2009)
Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study
Kimford J Meador;Gus A Baker;Nancy Browning;Morris J Cohen.
Lancet Neurology (2013)
Functional MRI cerebral activation and deactivation during finger movement
Jerry D. Allison;K. J. Meador;D. W. Loring;R. E. Figueroa.
In utero antiepileptic drug exposure: Fetal death and malformations
K. J. Meador;G. A. Baker;Richard Finnell;L. A. Kalayjian.
Unilateral cerebral inactivation produces differential left/right heart rate responses
E. Y. Zamrini;K. J. Meador;D. W. Loring;F. T. Nichols.
Cerebral language lateralization: evidence from intracarotid amobarbital testing
David W. Loring;Kimford J. Meador;Gregory P. Lee;Anthony M. Murro.
Cognitive Side Effects of Antiepileptic Drugs in Children
David W. Loring;Kimford J. Meador.
Determinants of quality of life in epilepsy
David W. Loring;Kimford J. Meador;Gregory P. Lee.
Epilepsy & Behavior (2004)
IQ at 6 years after in utero exposure to antiepileptic drugs: A controlled cohort study
Gus A. Baker;Rebecca L. Bromley;Maria Briggs;Christopher P. Cheyne.
Hallervorden-Spatz syndrome: clinical and magnetic resonance imaging correlations.
K. D. Sethi;R. J. Adams;D. W. Loring;T. El Gammal.
Annals of Neurology (1988)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: